Patients will be included as they are admitted to the facility. If they agree to participate, two urine samples will be collected at the start of treatment and at the end of the treatment sequence.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1\) Five patients for each of the following cancers :
Patients with high-risk localised prostate cancer eligible for high-dose radiotherapy, or
Patients with mHSPC eligible for docetaxel chemotherapy, or
Patients with mCRPC in second-line treatment eligible for luPSMA treatment, or
Patients with localised bladder cancer eligible for neoadjuvant chemotherapy or,
Patients with metastatic bladder cancer eligible for enfortumab vedotin (EV) plus pembrolizumab (EV-Pembro)
You may not be if
1. History of cancer in the 5 years prior to entering the trial other than basal cell skin cancer or cervical carcinoma in situ,
2. Women who are pregnant, likely to become pregnant or breastfeeding,
3. Persons deprived of their liberty, under judicial protection, under guardianship or placed under the authority of a guardian, Inability to undergo medical follow-up for the trial for geographical, social or psychological reasons.
Clareo Health | Feasibility Study of Urinary cfDNA Analysis as a Non-invasive Monitoring Tool in Patients With Prostate or Bladder Cancer
